The changing impact of vaccines in the COVID-19 pandemic

Q1 Medicine
J. A. Cohen, R. Stuart, J. Panovska-Griffiths, E. Mudimu, R. Abeysuriya, C. Kerr, M. Famulare, D. Klein
{"title":"The changing impact of vaccines in the COVID-19 pandemic","authors":"J. A. Cohen, R. Stuart, J. Panovska-Griffiths, E. Mudimu, R. Abeysuriya, C. Kerr, M. Famulare, D. Klein","doi":"10.1101/2022.03.10.22272222","DOIUrl":null,"url":null,"abstract":"The Omicron wave has left a global imprinting of immunity which changes the COVID landscape. In this study, we simulate six hypothetical variants emerging over the next year and evaluate the impact of existing and improved vaccines. We base our study on South Africa's infection- and vaccination-derived immunity. Our findings illustrate that variant-chasing vaccines will only add value above existing vaccines in the setting where a variant emerges if we can shorten the window between variant introduction and vaccine deployment to under three weeks, an impossible time-frame without significant NPI use. This strategy may have global utility, depending on the rate of spread from setting to setting. Broadly neutralizing and durable next-generation vaccines could avert over three-times as many deaths from an immune-evading variant compared to existing vaccines. Our results suggest it is crucial to develop next-generation vaccines and redress inequities in vaccine distribution to tackle future emerging variants.","PeriodicalId":38738,"journal":{"name":"Topics in antiviral medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Topics in antiviral medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2022.03.10.22272222","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

The Omicron wave has left a global imprinting of immunity which changes the COVID landscape. In this study, we simulate six hypothetical variants emerging over the next year and evaluate the impact of existing and improved vaccines. We base our study on South Africa's infection- and vaccination-derived immunity. Our findings illustrate that variant-chasing vaccines will only add value above existing vaccines in the setting where a variant emerges if we can shorten the window between variant introduction and vaccine deployment to under three weeks, an impossible time-frame without significant NPI use. This strategy may have global utility, depending on the rate of spread from setting to setting. Broadly neutralizing and durable next-generation vaccines could avert over three-times as many deaths from an immune-evading variant compared to existing vaccines. Our results suggest it is crucial to develop next-generation vaccines and redress inequities in vaccine distribution to tackle future emerging variants.
疫苗在COVID-19大流行中不断变化的影响
欧米克隆波在全球留下了免疫印记,改变了COVID的格局。在这项研究中,我们模拟了未来一年出现的六种假设变种,并评估了现有和改进的疫苗的影响。我们的研究基于南非的感染和疫苗衍生免疫。我们的研究结果表明,如果我们能够将变体引入和疫苗部署之间的窗口缩短到三周以内(如果没有显著的NPI使用,这是一个不可能的时间框架),那么追踪变体的疫苗只会在出现变体的情况下比现有疫苗增加价值。该策略可能具有全局效用,这取决于从一个设置到另一个设置的传播速率。与现有疫苗相比,广泛中和和持久的下一代疫苗可以避免三倍以上的免疫逃避变体造成的死亡。我们的研究结果表明,开发下一代疫苗和纠正疫苗分配中的不平等对于解决未来出现的变体至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Topics in antiviral medicine
Topics in antiviral medicine Medicine-Pharmacology (medical)
CiteScore
1.80
自引率
0.00%
发文量
10
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信